CT and MR imaging of chemotherapy-induced hepatopathy.

Chemotherapy Computed tomography Hepatopathy Magnetic resonance imaging Sinusoidal obstruction syndrome

Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 23 8 2019
medline: 2 10 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging.

Identifiants

pubmed: 31435760
doi: 10.1007/s00261-019-02193-y
pii: 10.1007/s00261-019-02193-y
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3312-3324

Auteurs

Federica Vernuccio (F)

Dipartimento Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 129, 90124, Palermo, Italy. federicavernuccio@gmail.com.
I.R.C.C.S. Centro Neurolesi Bonino Pulejo, Contrada Casazza, SS113, 98124, Messina, Italy. federicavernuccio@gmail.com.
Hôpitaux Universitaires Beaujon, Radiology, Université Paris VII, Clichy, France. federicavernuccio@gmail.com.

Marco Dioguardi Burgio (M)

Hôpitaux Universitaires Beaujon, Radiology, Université Paris VII, Clichy, France.
Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR 1149, INSERM, University Paris-Diderot, Paris, France.

Filippo Barbiera (F)

Azienda Sanitaria Provinciale Agrigento - UO Complessa Radiologia Distretto Ag 2 Sciacca-Ribera. Presidio Ospedaliero di Sciacca (AG), Sciacca, ‎Agrigento, Italy.

Silvestro Cusmà (S)

Oncologic Department, "La Maddalena", Palermo, Italy.

Giuseppe Badalamenti (G)

Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche (Di.Chir.On.S.), University Hospital "Paolo Giaccone", Palermo, Italy.

Massimo Midiri (M)

Dipartimento di Biomedicina, Neuroscienze e Diagnostica avanzata (BIND), University of Palermo, Palermo, Italy.

Valérie Vilgrain (V)

Hôpitaux Universitaires Beaujon, Radiology, Université Paris VII, Clichy, France.
Laboratory of Imaging Biomarkers, Center of Research on Inflammation, UMR 1149, INSERM, University Paris-Diderot, Paris, France.

Giuseppe Brancatelli (G)

Dipartimento di Biomedicina, Neuroscienze e Diagnostica avanzata (BIND), University of Palermo, Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH